Get the latest financial, economic and market news, instantly.
Subscribe
My Readse-paperNewslettersIFSC Code Finder NewWeb StoriesMintGenieFor You
Switch to the app Download App
e-paper
Home / Brand Stories / Labcorp Drug Development Selects Dr. Deepa Desai as Country Head for India

Labcorp Drug Development Selects Dr. Deepa Desai as Country Head for India

BRAND POST
Dr. D. Desai, the newly appointed Country Head for Labcorp Drug Development

Appointment Enhances Labcorp’s Commitment to Customers and Employees in the Region

Burlington, N.C., United States & Mumbai, Maharashtra, India – Business Wire India 

Burlington, N.C., United States & Mumbai, Maharashtra, India – Business Wire India 

Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Deepa Desai as senior vice president and country head of Labcorp Drug Development India. A longtime health care and life sciences leader, Desai brings extensive industry and scientific knowledge to the position, which gives her oversight of more than 6,000 employees. She most recently served as CEO of D Cube Consultancy, a firm she founded to help redesign and refocus organizations and teams in the healthcare space. “Dr. Desai’s broad experience and lengthy track record of driving strong business performance and scientific innovation on a global scale makes her exceptionally well-suited for the role," said Dr. Paul Kirchgraber, CEO of Labcorp Drug Development. “She has a proven passion for nurturing the careers of scientists and future leaders, and is committed to fostering an environment of diversity and inclusion. Dr. Desai will play a large part in furthering our mission to improve health and improve lives." Prior to establishing her consulting firm, Desai spent nearly two decades serving in various roles at a global contract research organization (CRO). These positions included global head of quality management systems, vice president and global lead for the company’s clinical delivery network, as well as global head of cardiac safety services. Desai also acted as a diversity and inclusion champion at the CRO, making her a key advocate and mentor within the company and across the broader health care community. “Joining Labcorp presents the opportunity to be part of a globally impactful organization with a rich history of advancing life-saving science and technology," Desai said. “I’m proud to work alongside such dedicated employees and incredible leaders, who have driven Labcorp’s important efforts in India for the benefit of patients, customers, clinicians and communities." An alumna of INSEAD, Desai was recognized in 2020 as one of PharmaVoice’s 100 Most Inspiring Leaders, and in 2019 she received a prestigious Luminary Award from the Healthcare Businesswomen Association. She earned her degree in homeopathic medicine and surgery from Mumbai University. 

Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Deepa Desai as senior vice president and country head of Labcorp Drug Development India. A longtime health care and life sciences leader, Desai brings extensive industry and scientific knowledge to the position, which gives her oversight of more than 6,000 employees. She most recently served as CEO of D Cube Consultancy, a firm she founded to help redesign and refocus organizations and teams in the healthcare space. “Dr. Desai’s broad experience and lengthy track record of driving strong business performance and scientific innovation on a global scale makes her exceptionally well-suited for the role," said Dr. Paul Kirchgraber, CEO of Labcorp Drug Development. “She has a proven passion for nurturing the careers of scientists and future leaders, and is committed to fostering an environment of diversity and inclusion. Dr. Desai will play a large part in furthering our mission to improve health and improve lives." Prior to establishing her consulting firm, Desai spent nearly two decades serving in various roles at a global contract research organization (CRO). These positions included global head of quality management systems, vice president and global lead for the company’s clinical delivery network, as well as global head of cardiac safety services. Desai also acted as a diversity and inclusion champion at the CRO, making her a key advocate and mentor within the company and across the broader health care community. “Joining Labcorp presents the opportunity to be part of a globally impactful organization with a rich history of advancing life-saving science and technology," Desai said. “I’m proud to work alongside such dedicated employees and incredible leaders, who have driven Labcorp’s important efforts in India for the benefit of patients, customers, clinicians and communities." An alumna of INSEAD, Desai was recognized in 2020 as one of PharmaVoice’s 100 Most Inspiring Leaders, and in 2019 she received a prestigious Luminary Award from the Healthcare Businesswomen Association. She earned her degree in homeopathic medicine and surgery from Mumbai University. 

Subscribe to Continue Reading

About LabcorpLabcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

Media Contact Details

Rachael Valdez, Labcorp, Media@Labcorp.com, 336 436 8263; Chas Cook, Labcorp, Investor@Labcorp.com, 336 436 5076

Disclaimer: This article is a paid publication and does not have journalistic/editorial involvement of Hindustan Times. Hindustan Times does not endorse/subscribe to the content(s) of the article/advertisement and/or view(s) expressed herein. Hindustan Times shall not in any manner, be responsible and/or liable in any manner whatsoever for all that is stated in the article and/or also with regard to the view(s), opinion(s), announcement(s), declaration(s), affirmation(s) etc., stated/featured in the same.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint.Download The Mint News App to get Daily Market Updates.